Skip to main content
Black Rose Industries Ltd logo

Black Rose Industries Ltd — Investor Relations & Filings

Ticker · BLACKROSE ISIN · INE761G01016 LEI · 335800DXOCHG9LIZ4W64 BSE.NS Manufacturing
Open in API
Filings indexed 694 across all filing types
Latest filing 2025-03-25 Regulatory Filings
Country IN India
Listing BSE.NS BLACKROSE

About Black Rose Industries Ltd

https://www.blackrosechemicals.com

Black Rose Industries Ltd is a specialty chemical company engaged in the manufacturing and distribution of performance chemicals. The company operates a large-scale acrylamide manufacturing facility utilizing advanced biocatalytic technology to produce high-purity monomeric acrylamide. Its product portfolio includes polyacrylamides, ceramic binders, and specialty chemicals tailored for applications in water treatment, pulp and paper, textiles, and oil and gas exploration. Beyond its manufacturing operations, the company acts as a strategic distribution partner for several global chemical producers, providing technical sales and supply chain management. The company emphasizes sustainable chemical processes and maintains rigorous quality standards to serve diverse industrial sectors across domestic and international markets.

Recent filings

Filing Released Lang Actions
Trading Window for dealing in securities of the Company shall be closed for the Company''s directors/officers and designated employees and their immediate relatives from 1st April, 2025 ....
Regulatory Filings Classification · 95% confidence The document is a letter dated 25th March 2025 from the Company Secretary & Compliance Officer of Black Rose Industries Limited addressed to the stock exchange (BSE Limited). It announces the closure of the trading window for dealing in securities of the company for directors, officers, designated employees, and their immediate relatives from 1st April 2025 until 48 hours after the declaration of financial results for the quarter and year ended 31st March 2025. This is a regulatory compliance announcement related to insider trading regulations and trading restrictions prior to financial results disclosure. The document does not contain any financial data, results, or detailed report but is an announcement of a trading window closure. It is short (1568 characters) and serves as a regulatory filing informing the exchange and public about the trading window closure period. Therefore, it fits best under Regulatory Filings (RNS).
2025-03-25 English
Transcript of Q3 FY25 Earnings Webinar held on Friday, 7th February 2025.
Call Transcript Classification · 100% confidence The document is a detailed transcript of a Q3 FY25 earnings webinar held by Black Rose Industries Limited. It includes a presentation of financial results, business updates, strategic outlook, and a Q&A session with shareholders. The content covers quarterly financial performance, business segments, market conditions, and future projects. The presence of detailed financial data and management discussion indicates this is a full transcript of an earnings call rather than a brief earnings release or a simple announcement. The document is not a report publication announcement or a certification. Therefore, the appropriate classification is a Call Transcript (CT).
2025-02-13 English
Pursuant to Regulation 30 and 46 read with Clause 15 of Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that ....
Report Publication Announcement Classification · 95% confidence The document is a short letter dated 7th February 2025 from Black Rose Industries Limited addressed to BSE Limited. It announces the uploading of the video recording and investor presentation for the Q3 FY25 earnings webinar on the company's website. The document references compliance with SEBI regulations and provides links to the materials but does not contain the actual financial data or detailed report itself. The length is only 1460 characters, indicating it is an announcement rather than a full report. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA) rather than the actual earnings release or investor presentation document.
2025-02-07 English
Performance Review Q3 FY25 and Business Update
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Performance Review Q3 FY25 and Business Update' and contains detailed financial data for the third quarter of fiscal year 2025, including standalone and consolidated revenue, EBITDA, PBT, and PAT figures. It also provides segment-wise results, key financial ratios, and a business update including operational and strategic initiatives. The document is dated February 5, 2025, and clearly covers a quarterly period with substantive financial data and analysis. It is not merely an announcement or a brief summary but a comprehensive report on quarterly performance and outlook. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2025
2025-02-05 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements Regulations) 2015, we wish to inform you that the earnings webinar is scheduled with the management of ....
Regulatory Filings Classification · 95% confidence The document is a notification about the scheduling of an earnings webinar to discuss the un-audited financial results for the quarter and nine months ended 31st December 2024. It includes an invitation to the webinar and registration details but does not contain any actual financial data or detailed financial results. The document is short (2215 characters) and serves as an announcement of an event related to earnings results rather than the earnings release itself or a detailed report. Therefore, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement about the earnings webinar schedule and correction of a previous filing's mistake in financial period reference.
2025-02-03 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements Regulations) 2015, we wish to inform you that an earnings webinar is scheduled with the management of ....
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the schedule of an earnings webinar for the quarter and nine months ended 31st December 2025. It references the discussion of audited financial results but does not contain any financial data or results itself. The document is an announcement of an event related to earnings, not the earnings release or report itself. The length is only 2074 characters, which is short and consistent with an announcement rather than a full report or transcript. Therefore, it fits best under the category of a Regulatory Filing (RNS) as a general regulatory announcement about an upcoming earnings call/webinar.
2025-02-03 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.